Cytek Biosciences logo
Cytek Biosciences
CTKB | NASDAQ
Chart Builder DCF Calculator
$5.63
-$0.21 (-3.60%)
At close: Nov 16, 2026, 4:00 PM ET
$5.79
+$0.16 (+2.84%)
After-hours: Nov 16, 2026, 7:10 PM ET

Cytek Biosciences Company Profile

Company profile explained

Company Profile

Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.

Key Executives

Name Position
Wenbin Jiang President, Chief Executive Officer & Chairman of the Board
Ilan Feuchtwang Chief Legal Officer
Ming Yan Chief Technology Officer & Director
William D. McCombe Chief Financial Officer
Patrik Sebastian Jeanmonod Head of Corporate Development Analytics
Paul D. Goodson Head of Investor Relations

Latest SEC Filings

Date Type Title
Sep 29, 2026 8-K Current Report
Aug 24, 2026 8-K Current Report
Aug 20, 2026 4 Filing
Aug 20, 2026 4 Filing
Aug 20, 2026 4 Filing
Aug 20, 2026 4 Filing
Aug 20, 2026 4 Filing
Aug 20, 2026 4 Filing
Aug 12, 2026 4 Filing
Aug 06, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
View All SEC Filings ➞
Cytek Biosciences
Cytek Biosciences logo
Country United States
IPO Date Jul 23, 2021
Industry Medical - Devices
Sector Healthcare
Employees 682
CEO Wenbin Jiang

Contact Details

47215 Lakeview Boulevard Fremont, California 94538-6407 United States

Stock Details

Ticker Symbol CTKB
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001831915
CUSIP Number 23285D109
ISIN Number US23285D1090
SIC Code 3826

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.